« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1
, Pages
73-79
, July 2005
IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: Effect of immunotherapy
-
Effects of natural allergen exposure and allergen immunotherapy on IL-9 protein (A), IL-9 mRNA (B), and c-Kit (C) expression in the nasal mucosa. Data shown are for out-of-season (pre) and peak-season
Effects of natural allergen exposure and allergen immunotherapy on IL-9 protein (A), IL-9 mRNA (B), and c-Kit (C) expression in the nasal mucosa. Data shown are for out-of-season (pre) and peak-season (post) nasal biopsy specimens in immunotherapy- and placebo-treated patients and nonatopic control subjects (peak only). Horizontal bars represent median values.
-
Expression of IL-9 protein (immunohistochemistry [IMH], 200× magnification; a, IL-9 mRNA (in situ hybridization [ISH], 200× magnification; b, c-Kit+ mast cells (IMH, 200× magnification; c, and colocalExpression of IL-9 protein (immunohistochemistry [IMH], 200× magnification; a, IL-9 mRNA (in situ hybridization [ISH], 200× magnification; b, c-Kit+ mast cells (IMH, 200× magnification; c, and colocalization of IL-9 mRNA to CD3+ T lymphocytes (IMH/ISH, 400× magnification; d, and colocalization of IL-9 protein to CD3+ T lymphocytes (double immunofluorescence, 400× magnification; e, and IL-9 protein to MBP+ eosinophils (double immunofluorescence, 400× magnification; f, Arrows show IL-9–expressing cells.
-
The contributions to IL-9 protein expression by T cells (CD3), eosinophils (major basic protein [MBP]), neutrophils (Elastase), and mast cells (Tryptase) are shown (A), and the proportions of T cells,The contributions to IL-9 protein expression by T cells (CD3), eosinophils (major basic protein [MBP]), neutrophils (Elastase), and mast cells (Tryptase) are shown (A), and the proportions of T cells, eosinophils, neutrophils, and mast cells expressing IL-9 protein are shown (B). Contributions to IL-9 mRNA expression and proportions of IL-9 mRNA–expressing leukocytes are also shown (C and D, respectively).
CP was supported by a research fellowship from the European Respiratory Society (Grant LTRF2002-037). This work was supported by the National Asthma Campaign (UK), Medical Research Council (UK), and ALK Abello (Horsholm, Denmark).Disclosure of potential conflict of interest: C. Pilette is supported by a European Respiratory Society (ERS) fellowship. S. Durham has consultant arrangements with and has received grants–research support from ALK-Abello and is on the speakers' bureau for ALK-Abello, GalxoSmithKline, Aventis, and UCB. All other authors—none disclosed.
PII: S0091-6749(05)00541-5
doi: 10.1016/j.jaci.2005.03.011
© 2005 American Academy of Allergy, Asthma and Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1
, Pages
73-79
, July 2005
